678 related articles for article (PubMed ID: 15039386)
1. Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association.
Mantegazza R; Cristaldini P; Bernasconi P; Baggi F; Pedotti R; Piccini I; Mascoli N; La Mantia L; Antozzi C; Simoncini O; Cornelio F; Milanese C
Int Immunol; 2004 Apr; 16(4):559-65. PubMed ID: 15039386
[TBL] [Abstract][Full Text] [Related]
2. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
Reindl M; Linington C; Brehm U; Egg R; Dilitz E; Deisenhammer F; Poewe W; Berger T
Brain; 1999 Nov; 122 ( Pt 11)():2047-56. PubMed ID: 10545390
[TBL] [Abstract][Full Text] [Related]
3. Activation of humoral immunity and eosinophils in neuromyelitis optica.
Correale J; Fiol M
Neurology; 2004 Dec; 63(12):2363-70. PubMed ID: 15623701
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis.
Lalive PH; Menge T; Delarasse C; Della Gaspera B; Pham-Dinh D; Villoslada P; von Büdingen HC; Genain CP
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2280-5. PubMed ID: 16461459
[TBL] [Abstract][Full Text] [Related]
5. Antibodies against glycosylated native MOG are elevated in patients with multiple sclerosis.
Gaertner S; de Graaf KL; Greve B; Weissert R
Neurology; 2004 Dec; 63(12):2381-3. PubMed ID: 15623705
[TBL] [Abstract][Full Text] [Related]
6. Recombinant forms of myelin antigens expressed on Chinese hamster ovary (CHO) cells as a tool for identification of autoantibodies in serum of multiple sclerosis patients.
Jaśkiewicz E; Michałowska-Wender G; Pyszczek A; Wender M
Folia Neuropathol; 2010; 48(1):45-8. PubMed ID: 20383810
[TBL] [Abstract][Full Text] [Related]
7. Elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis.
Karni A; Bakimer-Kleiner R; Abramsky O; Ben-Nun A
Arch Neurol; 1999 Mar; 56(3):311-5. PubMed ID: 10190821
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of antibodies against myelin oligodendrocyte glycoprotein in different clinical types of multiple sclerosis.
Zadro I; Brinar V; Horvat G; Brinar M
Clin Neurol Neurosurg; 2007 Jan; 109(1):23-6. PubMed ID: 16750597
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls.
Xiao BG; Linington C; Link H
J Neuroimmunol; 1991 Feb; 31(2):91-6. PubMed ID: 1991822
[TBL] [Abstract][Full Text] [Related]
10. Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects.
Lampasona V; Franciotta D; Furlan R; Zanaboni S; Fazio R; Bonifacio E; Comi G; Martino G
Neurology; 2004 Jun; 62(11):2092-4. PubMed ID: 15184621
[TBL] [Abstract][Full Text] [Related]
11. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
[TBL] [Abstract][Full Text] [Related]
12. Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases.
Di Pauli F; Mader S; Rostasy K; Schanda K; Bajer-Kornek B; Ehling R; Deisenhammer F; Reindl M; Berger T
Clin Immunol; 2011 Mar; 138(3):247-54. PubMed ID: 21169067
[TBL] [Abstract][Full Text] [Related]
13. Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis.
Zhou D; Srivastava R; Nessler S; Grummel V; Sommer N; Brück W; Hartung HP; Stadelmann C; Hemmer B
Proc Natl Acad Sci U S A; 2006 Dec; 103(50):19057-62. PubMed ID: 17142321
[TBL] [Abstract][Full Text] [Related]
14. Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis.
Egg R; Reindl M; Deisenhammer F; Linington C; Berger T
Mult Scler; 2001 Oct; 7(5):285-9. PubMed ID: 11724443
[TBL] [Abstract][Full Text] [Related]
15. Chitinase effects on immune cell response in neuromyelitis optica and multiple sclerosis.
Correale J; Fiol M
Mult Scler; 2011 May; 17(5):521-31. PubMed ID: 21159721
[TBL] [Abstract][Full Text] [Related]
16. Detection of anti-Nogo receptor autoantibody in the serum of multiple sclerosis and controls.
Onoue H; Satoh JI; Ogawa M; Tabunoki H; Yamamura T
Acta Neurol Scand; 2007 Mar; 115(3):153-60. PubMed ID: 17295709
[TBL] [Abstract][Full Text] [Related]
17. Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein (MOG).
Brehm U; Piddlesden SJ; Gardinier MV; Linington C
J Neuroimmunol; 1999 Jun; 97(1-2):9-15. PubMed ID: 10408984
[TBL] [Abstract][Full Text] [Related]
18. Elevated intrathecal myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis.
Klawiter EC; Piccio L; Lyons JA; Mikesell R; O'Connor KC; Cross AH
Arch Neurol; 2010 Sep; 67(9):1102-8. PubMed ID: 20837855
[TBL] [Abstract][Full Text] [Related]
19. Myelin oligodendrocyte glycoprotein antibodies in pathologically proven multiple sclerosis: frequency, stability and clinicopathologic correlations.
Pittock SJ; Reindl M; Achenbach S; Berger T; Bruck W; Konig F; Morales Y; Lassmann H; Bryant S; Moore SB; Keegan BM; Lucchinetti CF
Mult Scler; 2007 Jan; 13(1):7-16. PubMed ID: 17294606
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of anti-myelin antibodies in relapsing-remitting multiple sclerosis patients during different phases of disease activity and immunomodulatory therapy.
Angelucci F; Mirabella M; Frisullo G; Caggiula M; Tonali PA; Batocchi AP
Dis Markers; 2005; 21(2):49-55. PubMed ID: 15920290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
